Umoja Biopharma Revenue and Competitors
Estimated Revenue & Valuation
- Umoja Biopharma's estimated annual revenue is currently $48.2M per year.
- Umoja Biopharma's estimated revenue per employee is $201,000
- Umoja Biopharma's total funding is $263M.
Employee Data
- Umoja Biopharma has 240 Employees.
- Umoja Biopharma grew their employee count by 26% last year.
Umoja Biopharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder and CTO | Reveal Email/Phone |
2 | Co-founder & CEO | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Chief Operating Officer | Reveal Email/Phone |
7 | SVP, Translational Sciences | Reveal Email/Phone |
8 | EVP, Discovery Research & Vector Biology | Reveal Email/Phone |
9 | SVP, IT & Informatics | Reveal Email/Phone |
10 | SVP, Finance & Accounting | Reveal Email/Phone |
Umoja Biopharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.1M | 75 | 19% | N/A | N/A |
#2 | $0.8M | 8 | -50% | N/A | N/A |
#3 | $114M | 567 | 7% | N/A | N/A |
#4 | $19.3M | 96 | 13% | N/A | N/A |
#5 | $5.4M | 27 | 17% | N/A | N/A |
#6 | $17.7M | 88 | -45% | N/A | N/A |
#7 | $13.9M | 69 | 10% | N/A | N/A |
#8 | $5.4M | 27 | -10% | N/A | N/A |
#9 | $0.8M | 8 | 0% | $22M | N/A |
#10 | $5.4M | 27 | 29% | N/A | N/A |
What Is Umoja Biopharma?
Umoja is developing a new approach to cancer therapy that retools a patient's immune system in vivo, enhancing the body's natural capacity to fight cancer. We envision a world where all patients with cancer have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.
keywords:N/A
$263M
Total Funding
240
Number of Employees
$48.2M
Revenue (est)
26%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Umoja Biopharma News
2022-04-06 - Umoja Biopharma Presents Data on its iPSC-Based Cell ...
Umoja Biopharma Presents Data on its iPSC-Based Cell Therapy Platform at the American Association for Cancer Research (AACR) Annual Meeting...
2022-03-22 - Fred Hutch spinout Affini-T Therapeutics lands $175M for cell therapies to
treat solid tumors
Seattle biotech clout: Affini-T joins the ranks of cell therapy companies ... Umoja Biopharma recently raised $263 million in Series A and B...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $65.5M | 242 | N/A | N/A |
#2 | $54.9M | 243 | 22% | $82M |
#3 | $72.2M | 243 | 14% | N/A |
#4 | $72.2M | 243 | 6% | N/A |
#5 | $37.6M | 244 | N/A | N/A |